A peculiarity of the TP53 mutations in Kashmiri CRC tumours was the lack of deletions (0% versus 6.57% in IARC) and a higher prevalence of insertions 17.85% versus 1.4% in IARC R12, release). Here, TP53 is linked to neoplasm.